Medicare Enrolled

Dr. Sherry Solomon, MD

Ophthalmology · Scarsdale, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
700 WHITE PLAINS RD, Scarsdale, NY 10583
9147255400
In practice since 2006 (20 years)
NPI: 1275504722 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Solomon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Solomon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Solomon

Dr. Sherry Solomon is an ophthalmology specialist in Scarsdale, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Solomon performed 6,516 Medicare services across 3,080 unique beneficiaries.

Between the years covered by Open Payments, Dr. Solomon received a total of $5,620 from 26 pharmaceutical and/or device companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Solomon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 11% volume in NY $5,620 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,516
Medicare services
Top 11% in NY for ophthalmology
3,080
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~326 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,991 $34 $300
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
1,226 $78 $185
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
895 $20 $200
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
895 $34 $300
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
770 $101 $235
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
270 $104 $1,500
Aflibercept eye injection (Eylea) 220 $691 $1,295
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
105 $13 $200
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
67 $57 $125
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
46 $120 $400
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
31 $52 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,620
Total received (2018-2024)
Avg $803/year across 7 years
Top 18% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
202
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,620 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,592
2023
$1,581
2022
$1,242
2021
$253
2020
$247
2019
$648
2018
$57

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$468
Mallinckrodt Hospital Products Inc.
$391
Alcon Vision LLC
$340
Regeneron Healthcare Solutions, Inc.
$77
Tarsus Pharmaceuticals, Inc.
$69
ABBVIE INC.
$52
Bausch & Lomb Americas Inc.
$44
Oyster Point Pharma, Inc.
$39
Sandoz Inc.
$33
Rayner Intraocular Lenses Limited
$27
Genentech USA, Inc.
$23
Amgen Inc.
$15
Harrow Eye, LLC
$14
Top 3 companies account for 75.3% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$1,335
Alcon Vision LLC
$825
Astellas Pharma US Inc
$719
Novartis Pharmaceuticals Corporation
$596
Regeneron Healthcare Solutions, Inc.
$564
Apellis Pharmaceuticals, Inc.
$233
Sight Sciences, Inc.
$227
Coherus Biosciences Inc.
$153
Genentech USA, Inc.
$130
Alimera Sciences, Inc.
$130
RxSight Inc
$125
Bausch & Lomb Americas Inc.
$88
Tarsus Pharmaceuticals, Inc.
$69
Oyster Point Pharma, Inc.
$64
AbbVie Inc.
$56
ABBVIE INC.
$52
EyePoint Pharmaceuticals US, Inc.
$48
Ocular Therapeutix, Inc.
$37
Sandoz Inc.
$33
Sun Pharmaceutical Industries Inc.
$31
Rayner Intraocular Lenses Limited
$27
Shire North American Group Inc
$21
Allergan Inc.
$16
Amgen Inc.
$15
Harrow Eye, LLC
$14
Bausch & Lomb, a division of Bausch Health US, LLC
$13
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · BEOVU · BROMSITE · Cimerli · DEXTENZA · DUREZOL · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · Iluvien · Izervay · MIEBO · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · RAYNER CATARACT SET 1 · RXSIGHT CONTACT LENS · Rocklatan · Simbrinza · Susvimo · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · VABYSMO · VEVYE · VYZULTA · Vabysmo · XDEMVY · XIIDRA · XIPERE · YUTIQ · enVista MX60 IOL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Scarsdale?
Compare ophthalmologists in the Scarsdale area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
1,239
Per 100K population
124.3
County median income
$118,411
Nearest hospital
WHITE PLAINS HOSPITAL CENTER
3.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Solomon is a mixed practice specialist, with above-average Medicare volume (top 11% in NY), with low-engagement industry engagement in the top 18% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Solomon experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Solomon performed 1,991 retinal imaging (oct scan) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Solomon receive payments from pharmaceutical companies?
Yes. Dr. Solomon received a total of $5,620 from 26 companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Solomon's costs compare to other ophthalmologists in Scarsdale?
Dr. Solomon's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Solomon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →